Literature DB >> 19671742

Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression.

Mi Ra Kim1, Hong Seok Choi, Jin Won Yang, Byung Chul Park, Jung-Ae Kim, Keon Wook Kang.   

Abstract

Acquired resistance to tamoxifen (TAM) is a serious therapeutic problem in breast cancer patients. Here, we found that TAM-resistant MCF-7 cells (TAMR-MCF-7 cells) produced higher levels of vascular endothelial growth factor (VEGF) than control MCF-7 cells. Molecular analyses using reporter genes and Western blots supported the involvement of c-Jun/activator protein-1 and hypoxia-inducible factor 1alpha in enhanced VEGF transcription in TAMR-MCF-7 cells. Pin1, a peptidyl prolyl isomerase, was consistently overexpressed in TAMR-MCF-7 cells, and c-Jun/activator protein-1-dependent VEGF transcription in TAMR-MCF-7 cells was almost completely inhibited by Pin1 siRNA and by the Pin1 inhibitor juglone. Chick chorioallantoic membrane assays confirmed that the increased angiogenic intensity of TAMR-MCF-7 cells was significantly suppressed by Pin1 inhibition. These results show that Pin1 overexpression is closely associated with VEGF-mediated angiogenesis and suggest that Pin1 is a potential therapeutic target of excessive angiogenesis in TAM-resistant breast cancer cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671742     DOI: 10.1158/1535-7163.MCT-08-1061

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  20 in total

1.  A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.

Authors:  Ji Hye Park; Mee Young Ahn; Tae Hyung Kim; Sungpill Yoon; Keon Wook Kang; Jaewon Lee; Hyung Ryong Moon; Jee H Jung; Hae Young Chung; Hyung Sik Kim
Journal:  Invest New Drugs       Date:  2011-10-08       Impact factor: 3.850

2.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

3.  The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.

Authors:  Ying Liu; Rulla M Tamimi; Laura C Collins; Stuart J Schnitt; Hannah L Gilmore; James L Connolly; Graham A Colditz
Journal:  Breast Cancer Res Treat       Date:  2011-03-09       Impact factor: 4.872

Review 4.  The 3D in vivo chorioallantoic membrane model and its role in breast cancer research.

Authors:  Cynthia Kohl; Thiha Aung; Silke Haerteis; Atanas Ignatov; Olaf Ortmann; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-05       Impact factor: 4.322

5.  AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.

Authors:  Petreena S Campbell; Nicole Mavingire; Salma Khan; Leah K Rowland; Jonathan V Wooten; Anna Opoku-Agyeman; Ashley Guevara; Ubaldo Soto; Fiorella Cavalli; Andrea Irene Loaiza-Pérez; Gayathri Nagaraj; Laura J Denham; Olayemi Adeoye; Brittany D Jenkins; Melissa B Davis; Rachel Schiff; Eileen J Brantley
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

6.  The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells.

Authors:  Yini Yang; Lavanya Choppavarapu; Kun Fang; Alireza S Naeini; Bakhtiyor Nosirov; Jingwei Li; Ke Yang; Zhijing He; Yufan Zhou; Rachel Schiff; Rong Li; Yanfen Hu; Junbai Wang; Victor X Jin
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-09-19       Impact factor: 4.490

7.  A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders.

Authors:  Andrea Huwiler; Florence Bourquin; Nataliya Kotelevets; Oleksandr Pastukhov; Guido Capitani; Markus G Grütter; Uwe Zangemeister-Wittke
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

Review 8.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

9.  Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.

Authors:  Erying Zhang; Xiaowei Feng; Fei Liu; Peihua Zhang; Jie Liang; Xudong Tang
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

10.  Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.

Authors:  S Rezania; S Kammerer; C Li; B Steinecker-Frohnwieser; A Gorischek; T T J DeVaney; S Verheyen; C A Passegger; N Ghaffari Tabrizi-Wizsy; H Hackl; D Platzer; A H Zarnani; E Malle; S W Jahn; T Bauernhofer; W Schreibmayer
Journal:  BMC Cancer       Date:  2016-08-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.